首页|肺腺癌恶性胸水细胞学标本PD-L1的表达及与临床和分子特征关系

肺腺癌恶性胸水细胞学标本PD-L1的表达及与临床和分子特征关系

扫码查看
目的:分析PD-L1(细胞程序性死亡-配体1)在肺腺癌患者恶性胸水脱落细胞中的表达,分析PD-L1与肺腺癌患者临床病理参数的关系.方法:采用免疫组化方法检测54例肺腺癌患者恶性胸水中的脱落细胞标本中PD-L1的表达,同时检测73例肺腺癌组织标本中PD-L1的表达,分析两者之间表达一致性.结果:在54例细胞标本中PD-L1阳性率68.5%,而73例组织标本中仅为53.4%(P>0.05);其中31例肺腺癌患者既有恶性胸水细胞标本,也有组织标本,恶性胸水中肿瘤细胞PD-L1阳性比例TPS 1%-49%为26%,TPS≥50%为39%,PD-L1在同一患者的组织学和细胞学标本中的表达阳性率一致性尚可(Kappa=0.49,P<0.05).恶性胸水细胞中PD-L1表达与淋巴结转移状态相关(P<0.05),而与患者性别、年龄、远处转移等均无相关性(P>0.05).结论:在肺腺癌恶性胸水细胞学标本中检测PD-L1的结果可靠,在组织学标本无法获得的情况下,可用恶性胸水细胞学标本进行PD-L1检测.
The Expression of PD-L1 in Malignant Pleural Fluid Cytological Specimens of Lung Adenocarcinoma and the Relationship between Clinical and Molecular Characteristics
Objective:To evaluate the relationship between PD-L1 expression and clinicopathological in lung adenocarcinoma.Methods:54 cases of malignant pleural effusion and 73 cases of lung adenocarcinoma were detected by immunohistochemical.Results:The positive rate of PD-L1 in malignant pleural fluid was 68.5%in cytological specimens and 53.4%in histological specimen(P>0.05).Among them,31patients had malignant pleural fluid cytological and histological specimens.The positive proportion of PD-L1 expression in malignant pleural fluid was 26%in TPS from 1%to 49%,and 39%in TPS≥50%.The expression of PD-L1 was moderately consistent between then(Kappa=0.49,P<0.05).PD-L1 expression was correlated with lymph node metastasis status(P<0.05)only.Conclusion:PD-L1 can be detected reliably in malignant pleural fluid cytological specimens of lung adenocarcinoma.

lung adenocarcinomamalignant pleural effusionPD-L1

黄巍、孙世珺、曹晓珊、雷昊鑫、黄伟钊

展开 >

广东省中山市人民医院病理科(528400)

广东省中山市人民医院心胸外科(528400)

肺腺癌 恶性胸水 PD-L1

2024

岭南急诊医学杂志
广东省医学会

岭南急诊医学杂志

影响因子:0.437
ISSN:1671-301X
年,卷(期):2024.29(6)